Preliminary Q1 2026 Results: Revenue and Operating Profit Decline, Net Income Turns Positive
-
Consolidated preliminary Q1 2026 results: Revenue 235.5bn KRW (YoY -11.1%), Operating profit 2.9bn (-41.1%), Net income 2.2bn (swing to profit)
-
QoQ changes: Revenue -6.0%, Operating profit -25.1%, Net income -33.7% (previous quarter net income 33.3bn)
-
Controlling interests net income 14.5bn (swing from -66.2bn in prior year same period)
-
Figures are preliminary and unaudited, subject to change
KOSDAQ Filing Information
-
-
Consolidated Financial Statements Basis Operating (Provisional) Results (Fair Disclosure)
-
Company: Green Cross Medical Science (142280)
-
Submission: Green Cross Medical Science Corporation
-
Under KRX KOSDAQ Market Division
-
-
Shares: 21,741,926
-
Price: 3,870 KRW
-
Market Cap: 84.1 B KRW